Retender radar: UK public contracts ending soon

Every contract on Find a Tender with a published end date in the future, one row per contract (lot). A contract ending is a procurement starting — unless the buyer uses a published extension option, which the row shows. Frameworks and DPS are marked: what ends there is the vehicle, not one supplier’s contract.

When contracts end · Medical equipments, pharmaceuticals
i

When contracts here run out.

Published contracts by their end date. No end date, not counted.

A likely retender, not a certain one.

902 contracts end within 24 months, 1,006 in total · £90m published GBP value, exc. VAT, in the next 12 months (framework ceilings included, not a spend forecast).

  1. Next 3 months22
  2. 3–6 months277
  3. 6–12 months292
  4. 12–24 months311

By sector, next 12 months
i

When contracts here run out.

Published contracts by their end date. No end date, not counted.

A likely retender, not a certain one.

Contracts ending in the chosen window, by category.

CPV division of the procedure; a contract with several divisions counts in each.

Contracts ending in the next 12 months

Showing 301–400

  1. Ends · in 111 daysFramework re-let

    Wave 15b - Orals (plus non-parenteral) products

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Brown and Burk UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Jan 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  2. Ends · in 111 daysFramework re-let

    Wave 15b - Orals (plus non-parenteral) products

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Alissa Healthcare Research Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Jan 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  3. Ends · in 111 daysFramework re-let

    Wave 15b - Orals (plus non-parenteral) products

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Sandoz

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Jan 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  4. Ends · in 111 daysFramework re-let

    Wave 15b - Orals (plus non-parenteral) products

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Scope Ophthalmics Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Jan 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  5. Ends · in 111 daysFramework re-let

    Wave 15b - Orals (plus non-parenteral) products

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Milpharm Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Jan 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  6. Ends · in 111 daysFramework re-let

    Wave 15b - Orals (plus non-parenteral) products

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: MSN Laboratories Europe Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Jan 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  7. Ends · in 111 daysFramework re-let

    Wave 15b - Orals (plus non-parenteral) products

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Biocon

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Jan 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  8. Ends · in 111 daysFramework re-let

    Wave 15b - Orals (plus non-parenteral) products

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: ACCORD-UK LTD

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Jan 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  9. Ends · in 111 daysFramework re-let

    Wave 15b - Orals (plus non-parenteral) products

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Medreich PLC

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Jan 2027 · start not published
    Reference
    ocds-h6vhtk-04e2d4
  10. Ends · in 120 daysFramework re-letPanel · 10 suppliers

    Veterinary imaging Systems

    APUC Ltd · Nationwide (UK)

    Panel: Aquilant Endoscopy Ltd, Canon Medical Systems, IMV imaging UK Ltd +7 more

    • Agricultural, farming, fishing, forestry and related products
    • Animal products
    • Animal products and related products
    Contract value
    £20mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 9 Feb 2027 · start not published
    Reference
    ocds-h6vhtk-044583
  11. Ends · in 120 daysFramework re-letPanel · 10 suppliers

    Veterinary imaging Systems

    APUC Ltd · Nationwide (UK)

    Panel: Aquilant Endoscopy Ltd, Canon Medical Systems, IMV imaging UK Ltd +7 more

    • Agricultural, farming, fishing, forestry and related products
    • Animal products
    • Animal products and related products
    Contract value
    £20mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    10 Feb 2024 → 9 Feb 2027 · 2.9 yrs
    Reference
    ocds-h6vhtk-044583
  12. Ends · in 139 daysFramework re-letPanel · 31 suppliers

    NP49425 Generic and Biosimilar Transition Medicines

    The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland

    Panel: AOP Orphan Ltd, Accord Healthcare Ltd, Amarox Limited +28 more

    • Pharmaceutical products
    Contract value
    £64mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 28 Feb 2027 · start not published
    Reference
    ocds-h6vhtk-0581ea
  13. Ends · in 139 daysFramework re-letPanel · 5 suppliers

    Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)

    The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland

    Panel: Celltrion Healthcare United Kingdom Limited, Fresenius Kabi Limited, Janssen-Cilag Ltd +2 more

    • Pharmaceutical products
    Contract value
    £27mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 28 Feb 2027 · start not published
    Reference
    ocds-h6vhtk-0581ea
  14. Ends · in 139 daysFramework re-letPanel · 2 suppliers

    Cytokine Modulators (Omalizumab)

    The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland

    Panel: Celltrion Healthcare United Kingdom Limited, Mercury Pharmaceuticals Limited

    • Pharmaceutical products
    Contract value
    £9.3mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 28 Feb 2027 · start not published
    Reference
    ocds-h6vhtk-0581ea
  15. Ends · in 149 daysFramework re-let

    Supply of Antisera Reagents

    NHS Blood and Transplant · NHS & health · Nationwide (UK)

    Incumbent: Bio-Rad Laboratories Limited

    • Blood-testing reagents
    • Diagnostic kits
    Contract value
    £1.9mceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 10 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-038a2d
  16. Ends · in 149 daysFramework re-let

    Supply of Antisera Reagents

    NHS Blood and Transplant · NHS & health · Nationwide (UK)

    Incumbent: IBG Immucor Ltd

    • Blood-testing reagents
    • Diagnostic kits
    Contract value
    £1.9mceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 10 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-038a2d
  17. Ends · in 149 daysFramework re-let

    Supply of Antisera Reagents

    NHS Blood and Transplant · NHS & health · Nationwide (UK)

    Incumbent: Alpha Laboratories Limited

    • Blood-testing reagents
    • Diagnostic kits
    Contract value
    £1.9mceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 10 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-038a2d
  18. Ends · in 149 daysFramework re-let

    Supply of Antisera Reagents

    NHS Blood and Transplant · NHS & health · Nationwide (UK)

    Incumbent: Alba Bioscience Limited

    • Blood-testing reagents
    • Diagnostic kits
    Contract value
    £1.9mceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 10 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-038a2d
  19. Ends · in 149 daysFramework re-let

    Supply of Antisera Reagents

    NHS Blood and Transplant · NHS & health · Nationwide (UK)

    Incumbent: Lorne Laboratories Limited

    • Blood-testing reagents
    • Diagnostic kits
    Contract value
    £1.9mceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 10 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-038a2d
  20. Ends · in 150 daysExtension option · up to 11 Mar 2029

    Supply of Naloxone Nasal Spray

    Home Office · Central government · Nationwide (UK)

    Incumbent: Orion Medical Supplies Ltd

    • Injectable solutions
    Contract value
    £169k
    Annual run-rate
    £169kvalue ÷ published term
    Term
    12 Mar 2026 → 11 Mar 2027 · 11 months · up to 11 Mar 2029 with extensions
    Reference
    ocds-h6vhtk-060344
  21. Ends · in 170 daysFramework re-letPanel · 5 suppliers

    239_24 Provision of Washroom Services

    Leeds Beckett University · Education · Nationwide (UK), Yorkshire and the Humber, Greater London

    Panel: Elis Cleanroom, Hygiene Solutions & Systems LTD, Personnel Hygiene Services Ltd T/A PHS Group Plc +2 more

    • Cleaning and sanitation services
    • Facility related sanitation services
    • Hand care products
    Contract value
    £120mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 31 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-042b9b
  22. Ends · in 170 days

    Tender for the provision of the Technology Enabled Care Service (TECS) in Herefordshire

    Herefordshire Council · Local authority · West Midlands

    Incumbent: Nottingham Rehab Limited

    • Health and social work services
    • Medical equipments, pharmaceuticals and personal care products
    • Other community, social and personal services
    Contract value
    £2.5m
    Annual run-rate
    —start date not published
    Term
    Ends 31 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-04be9e
  23. Ends · in 170 days

    Rabies vaccine

    Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)

    Incumbent: Valneva UK Ltd

    • Vaccines
    Contract value
    £1.9m
    Annual run-rate
    —start date not published
    Term
    Ends 31 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-034816
  24. Ends · in 170 daysFramework re-let

    The Provision of Nicotine Replacement Therapy for North Northamptonshire Council

    North Northamptonshire Council · Local authority · East Midlands

    Incumbent: Sigma Pharmaceuticals plc

    • Nicotine substitutes
    Contract value
    £400kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-0392cf
  25. Ends · in 170 daysFramework re-letExtension option · up to 31 Mar 2029Buyer plans to re-tender 27 Jan 2029

    West Northamptonshire Council - Point of Care Testing (POCT) Equipment and Support Framework for NHS Health Check Services

    West Northamptonshire Council · Local authority · East Midlands

    Incumbent: BHR Pharmaceuticals Ltd

    • Diagnostic devices
    Contract value
    £350kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    8 May 2026 → 31 Mar 2027 · 10 months · up to 31 Mar 2029 with extensions
    Reference
    ocds-h6vhtk-060feb
  26. Ends · in 170 daysExtension option · up to 31 Mar 2032

    Provision of Minor Maintenance and Cleansing of Public Conveniences Lot 2

    Swale Borough Council · Local authority · South East England

    Incumbent: Monitor Cleaning Services Ltd

    • Building-cleaning services
    • Cleaning and sanitation services
    • Cleaning services
    Contract value
    £337k
    Annual run-rate
    £368kvalue ÷ published term
    Term
    1 May 2026 → 31 Mar 2027 · 11 months · up to 31 Mar 2032 with extensions
    Reference
    ocds-h6vhtk-065b95
  27. Ends · in 170 days

    NGH - Nurse Call Upgrade

    Northampton General Hospital NHS Trust · Central government · East Midlands

    Incumbent: H.R.MANN LIMITED

    • Patient-monitoring system
    Contract value
    £309k
    Annual run-rate
    —not computed
    Term
    1 Oct 2026 → 31 Mar 2027 · 6 months
    Reference
    ocds-h6vhtk-06d30d
  28. Ends · in 170 days

    CWC23163 Supply of Combi Nicotine Replacement Therapy (NRT)

    Wolverhampton City Council · Local authority · West Midlands

    Incumbent: Central Health Solutions Ltd

    • Medical equipments, pharmaceuticals and personal care products
    Contract value
    £308k
    Annual run-rate
    —start date not published
    Term
    Ends 31 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-0437d9
  29. Ends · in 170 daysFramework re-let

    YPO 1260 ESPO 239_24 Washroom Services - Further competition

    Leeds Beckett University · Education · Nationwide (UK), Yorkshire and the Humber, Greater London

    Incumbent: Rentokil Initial UK Ltd

    • Cleaning and sanitation services
    • Facility related sanitation services
    • Hand care products
    Contract value
    £240kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-042b9b
  30. Ends · in 170 days

    CBC-1631-T-RM Toxicology/Coroner Services

    Central Bedfordshire Council · Local authority · East of England

    Incumbent: Central Bedfordshire Council

    • Pathology services
    • Post-mortem and mortuary equipment and supplies
    Contract value
    £229k
    Annual run-rate
    —start date not published
    Term
    Ends 31 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-042afb
  31. Ends · in 170 daysExtension option · up to 31 Mar 2029

    IPMO 2168.12 - High-Speed X-Ray

    Defence Science and Technology Laboratory · Central government · Nationwide (UK)

    Incumbent: Dynamic Research Innovations Incorporated

    • Diagnostic X-ray system
    • X-ray developers
    • X-ray microanalysers
    Contract value
    £222k
    Annual run-rate
    £168kvalue ÷ published term
    Term
    5 Dec 2025 → 31 Mar 2027 · 1.3 yrs · up to 31 Mar 2029 with extensions
    Reference
    ocds-h6vhtk-058c24
  32. Ends · in 170 daysFramework re-let

    NC766 Washroom Services

    Leeds Beckett University · Education · Nationwide (UK), Yorkshire and the Humber, Greater London

    Incumbent: Personnel Hygiene Services Ltd T/A PHS Group Plc

    • Cleaning and sanitation services
    • Facility related sanitation services
    • Hand care products
    Contract value
    £160kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-042b9b
  33. Ends · in 170 days

    Single-molecule counting and digital quantification of RNA molecules instrument

    Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · Central government · Nationwide (UK)

    Incumbent: Bruker Spatial Biology, Inc.

    • Medical equipments
    Contract value
    £111k
    Annual run-rate
    £148kvalue ÷ published term
    Term
    1 Jul 2026 → 31 Mar 2027 · 9 months
    Reference
    ocds-h6vhtk-059f67
  34. Ends · in 170 daysFramework re-let

    NC766 Washroom Services

    Leeds Beckett University · Education · Nationwide (UK), Yorkshire and the Humber, Greater London

    Incumbent: Rentokil Initial t/a Initial Washroom Hygiene

    • Cleaning and sanitation services
    • Facility related sanitation services
    • Hand care products
    Contract value
    £99kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-042b9b
  35. Ends · in 170 days

    Supply of BD Glucan Test kits

    University Hospitals of Derby and Burton NHS Foundation Trust · Central government · Nationwide (UK)

    Incumbent: IMMY MDx Ltd

    • Diagnostic agents
    Contract value
    £82k
    Annual run-rate
    £82kvalue ÷ published term
    Term
    1 Apr 2026 → 31 Mar 2027 · 11 months
    Reference
    ocds-h6vhtk-065fab
  36. Ends · in 170 days

    Orthotic Consumables

    The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust · Central government

    Incumbent: Allard Support UK Ltd

    • Orthopaedic supplies
    • Orthotic services
    Contract value
    £81k
    Annual run-rate
    £81kvalue ÷ published term
    Term
    1 Apr 2026 → 31 Mar 2027 · 11 months
    Reference
    ocds-h6vhtk-066466
  37. Ends · in 170 days

    Ophthalmic Consumables

    The Shrewsbury and Telford Hospital NHS Trust · Central government

    Incumbent: M.I.S.S. Ophthalmics Limited

    • Medical consumables
    Contract value
    £33k
    Annual run-rate
    £33kvalue ÷ published term
    Term
    1 Apr 2026 → 31 Mar 2027 · 11 months
    Reference
    ocds-h6vhtk-0660ac
  38. Ends · in 170 days

    BCG

    Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)

    Incumbent: AJ Vaccines A/S

    • Vaccines
    Contract value
    £1
    Annual run-rate
    —start date not published
    Term
    Ends 31 Mar 2027 · start not published
    Reference
    ocds-h6vhtk-034f1d
  39. Ends · in 200 days

    European Viper Antivenom (2024)

    Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)

    Incumbent: Flynn Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1
    Annual run-rate
    value ÷ published term
    Term
    1 May 2024 → 30 Apr 2027 · 2.9 yrs
    Reference
    ocds-h6vhtk-03b697
  40. Ends · in 200 days

    European Viper Antivenom (2024)

    Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)

    Incumbent: Flynn Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1
    Annual run-rate
    value ÷ published term
    Term
    1 May 2024 → 30 Apr 2027 · 2.9 yrs
    Reference
    ocds-h6vhtk-03b697
  41. Ends · in 200 daysFramework re-let

    Standard Half-life Recombinant Factor VIII

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Pfizer Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  42. Ends · in 200 daysFramework re-let

    rFIX - Standard Half Life

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Pfizer Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  43. Ends · in 200 daysFramework re-let

    rFIX - Standard Half Life

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Takeda UK Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  44. Ends · in 200 daysFramework re-let

    Recombinant Factor VII

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Novo Nordisk

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  45. Ends · in 200 daysFramework re-let

    Recombinant Factor VII

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: LFB

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  46. Ends · in 200 daysFramework re-let

    Porcine Factor VIII - susoctocog alfa

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Takeda UK Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  47. Ends · in 200 daysFramework re-let

    Factor VIII Inhibitor Bypassing Fraction

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Takeda UK Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  48. Ends · in 200 daysFramework re-let

    Factor IX - High Purity Factor IX

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: BIO PRODUCTS LABORATORY LIMITED

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  49. Ends · in 200 daysFramework re-let

    Factor X

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: BIO PRODUCTS LABORATORY LIMITED

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  50. Ends · in 200 daysFramework re-let

    Factor XIII - Plasma Derived

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: CSL BEHRING UK LIMITED

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  51. Ends · in 200 daysFramework re-let

    Factor XIII - Recombinant

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Novo Nordisk

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  52. Ends · in 200 daysFramework re-let

    Standard Half-life Recombinant Factor VIII

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Takeda UK Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  53. Ends · in 200 daysFramework re-let

    Von willebrands factor / Factor VIII

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Octapharma Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  54. Ends · in 200 daysFramework re-let

    Von willebrands factor / Factor VIII

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: CSL BEHRING UK LIMITED

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  55. Ends · in 200 daysFramework re-let

    Von willebrands factor - Plasma Derived

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: LFB

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  56. Ends · in 200 daysFramework re-let

    Von willebrands factor - Recombinant

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Takeda UK Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  57. Ends · in 200 daysFramework re-let

    Fibrinogen Concentrate

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: LFB

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  58. Ends · in 200 daysFramework re-let

    Fibrinogen Concentrate

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Octapharma Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  59. Ends · in 200 daysFramework re-let

    Fibrinogen Concentrate

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: CSL BEHRING UK LIMITED

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  60. Ends · in 200 daysFramework re-let

    Prothrombin Complex dried

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Takeda UK Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  61. Ends · in 200 daysFramework re-let

    Prothrombin Complex dried

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Octapharma Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  62. Ends · in 200 daysFramework re-let

    Prothrombin Complex dried

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: CSL BEHRING UK LIMITED

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  63. Ends · in 200 daysFramework re-let

    Standard Half-life Recombinant Factor VIII

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Octapharma Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  64. Ends · in 200 daysFramework re-let

    Protein C Concentrate

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Takeda UK Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  65. Ends · in 200 daysFramework re-let

    Fresh Frozen Plasma (all blood groups)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Octapharma Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  66. Ends · in 200 daysFramework re-let

    Enhanced Half-life Recombinant Factor VIII

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Novo Nordisk

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  67. Ends · in 200 daysFramework re-let

    Enhanced Half-life Recombinant Factor VIII

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Sobi (Swedish Orphan Biovitrum Ltd)

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  68. Ends · in 200 daysFramework re-let

    Emicizumab

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Roche Products Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  69. Ends · in 200 daysFramework re-let

    Eftrenonacog alfa (rFIX EHL)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Sobi (Swedish Orphan Biovitrum Ltd)

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  70. Ends · in 200 daysFramework re-let

    albutrepenonacog alfa (rFIX EHL)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: CSL BEHRING UK LIMITED

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  71. Ends · in 200 daysFramework re-let

    nonacog beta pegol (rFIX EHL)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Novo Nordisk

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-043b0e
  72. Ends · in 200 days

    Varicella-zoster immunoglobulin (VZIG) 2025

    Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)

    Incumbent: BIO PRODUCTS LABORATORY LIMITED

    • Immune sera and immunoglobulins
    Contract value
    £1
    Annual run-rate
    —start date not published
    Term
    Ends 30 Apr 2027 · start not published
    Reference
    ocds-h6vhtk-047b9e
  73. Ends · in 200 days

    Varicella-zoster immunoglobulin (VZIG) 2025

    Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)

    Incumbent: BIO PRODUCTS LABORATORY LIMITED

    • Immune sera and immunoglobulins
    Contract value
    £1
    Annual run-rate
    £1value ÷ published term
    Term
    1 May 2025 → 30 Apr 2027 · 1.9 yrs
    Reference
    ocds-h6vhtk-047b9e
  74. Ends · in 200 days

    Varicella-zoster immunoglobulin (VZIG) 2025

    Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)

    Incumbent: Grifols UK

    • Immune sera and immunoglobulins
    Contract value
    £1
    Annual run-rate
    £1value ÷ published term
    Term
    1 May 2025 → 30 Apr 2027 · 1.9 yrs
    Reference
    ocds-h6vhtk-047b9e
  75. Ends · in 231 daysFramework re-letExtension option · up to 31 May 2029Panel · 5 suppliers

    Lot 2 - CM/PHS/25/5728/02

    NHS England · Central government · Nationwide (UK), North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands

    Panel: Bayer Plc, Biosimilar Collaborations Ireland Limited, Celltrion Healthcare Uk Ltd +2 more

    • Pharmaceutical products
    • Various medicinal products
    Contract value
    £783mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    1 Dec 2025 → 31 May 2027 · 1.4 yrs · up to 31 May 2029 with extensions
    Reference
    ocds-h6vhtk-055064
  76. Ends · in 231 daysFramework re-letExtension option · up to 31 May 2029Panel · 14 suppliers

    Lot 1 - CM/PHS/25/5728/01

    NHS England · Central government · Nationwide (UK), North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands

    Panel: Abbvie Ltd, Alimera Sciences, Bayer Plc +11 more

    • Pharmaceutical products
    • Various medicinal products
    Contract value
    £689mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    1 Dec 2025 → 31 May 2027 · 1.4 yrs · up to 31 May 2029 with extensions
    Reference
    ocds-h6vhtk-055064
  77. Ends · in 231 daysFramework re-letExtension option · up to 31 Jan 2030Panel · 21 suppliers

    NHS National Framework for Generics Housekeeping Lot 1 - Oral Products

    NHS England · Central government · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England

    Panel: ACCORD-UK LTD, Alissa Healthcare Research Limited, Brown and Burk UK Ltd +18 more

    • Pharmaceutical products
    Contract value
    £18mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    1 Feb 2026 → 31 May 2027 · 1.3 yrs · up to 31 Jan 2030 with extensions
    Reference
    ocds-h6vhtk-058823
  78. Ends · in 231 daysFramework re-letExtension option · up to 31 May 2028Panel · 16 suppliers

    Lot 1 - CM/PHG/23/5699/01 Oral (plus non-parenteral) products

    NHS England · Central government · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England

    Panel: Amarox Limited, Brown and Burk UK Ltd, Celix Pharma Ltd. +13 more

    • Pharmaceutical products
    Contract value
    £18mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    1 Jun 2026 → 31 May 2027 · 11 months · up to 31 May 2028 with extensions
    Reference
    ocds-h6vhtk-05193a
  79. Ends · in 231 daysFramework re-letPanel · 29 suppliers

    Lot 1.2 - Technology Enabled Care (Telecare) services

    ESPO · Nationwide (UK)

    Panel: Alcove Limited, Appello Smart Living Solutions, BDS (Northern) Ltd t/a BDS Recruitment +26 more

    • Alarm-monitoring services
    • Health and social work services
    • Installation services of communications equipment
    Contract value
    £8.8mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-04c625
  80. Ends · in 231 daysFramework re-letPanel · 22 suppliers

    Lot 1.1 - Technology Enabled Care (Telecare) products and associated services

    ESPO · Nationwide (UK)

    Panel: Access UK Ltd, Alcove Limited, Alertacall Limited +19 more

    • Alarm-monitoring services
    • Health and social work services
    • Installation services of communications equipment
    Contract value
    £5.6mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-04c625
  81. Ends · in 231 daysFramework re-letPanel · 13 suppliers

    Lot 2.1 - Telehealth products and associated services

    ESPO · Nationwide (UK)

    Panel: Abilia Ltd, Baywater Healthcare UK Limited, Broomwell Healthwatch Limited +10 more

    • Alarm-monitoring services
    • Health and social work services
    • Installation services of communications equipment
    Contract value
    £800kceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-04c625
  82. Ends · in 231 daysFramework re-letPanel · 16 suppliers

    Lot 2.2 - Telehealth services

    ESPO · Nationwide (UK)

    Panel: Baywater Healthcare UK Limited, Broomwell Healthwatch Limited, EVONDOS OY +13 more

    • Alarm-monitoring services
    • Health and social work services
    • Installation services of communications equipment
    Contract value
    £800kceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-04c625
  83. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Milpharm Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  84. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Roma Pharmaceuticals Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  85. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Perennial Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  86. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Consilient Health Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  87. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Pfizer Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  88. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Rosemont Pharmaceuticals Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  89. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: GLAXOSMITHKLINE UK LIMITED

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  90. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Aventis Pharma Ltd Trading As Sanofi

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  91. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Sandoz

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  92. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Flynn Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  93. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Dr Reddy's Laboratories (UK) Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  94. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Kent Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  95. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Glenmark Pharmaceuticals Europe Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  96. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Esteve Pharmaceuticals Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  97. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Healthcare Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  98. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Ranbaxy (UK) Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  99. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: CST Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  100. Ends · in 231 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Teva UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
How to read the radar
  • End date is the contract period end the buyer published on Find a Tender. Contracts without an end date are not on the radar.
  • Extension option means the notice publishes a renewal or option clause; the buyer may extend instead of retendering. Hide them to see contracts that must be re-procured.
  • Incumbent is the canonical supplier on the award behind the contract. A panel (several suppliers on one award) is shown as a panel — no single incumbent is invented.
  • Annual run-rate = published GBP value ÷ published term, only for a single supplier, a term of six months or more and a plain contract (not a framework or DPS ceiling).
  • Counts are exact from the nightly projection when you filter by horizon and sector only; any other filter shows a bounded total — exact up to 1,000 contracts, an honest “1,000+” floor above that.